Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Candel Therapeutics Inc (CADL)

Candel Therapeutics Inc (CADL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Biotech Companies Making Strides in Pancreatic Cancer Treatment and Early Detection Newswire.ca - Wed May 15, 10:14AM CDT

/CNW/ -- USA News Group – Hope is rising in the fight against one of the deadliest cancers in the world, as a new study recently claimed that a blood test can...

ONCY : 1.1300 (-2.59%)
CADL : 12.70 (-9.29%)
ABVC : 1.0600 (-1.85%)
CTMX : 2.0000 (+2.04%)
AMGN : 314.72 (-1.35%)
ONC.TO : 1.55 (-1.27%)
Biotech Innovations Drive Hope in Global Fight Against Pancreatic Cancer BayStreet.ca - Wed May 15, 8:50AM CDT

USA News Group – Hope is rising in the fight against one of the deadliest cancers in the world, as a new study recently claimed that a blood test can accurately detect early-stage pancreatic cancer with...

ONCY : 1.1300 (-2.59%)
ONC.TO : 1.55 (-1.27%)
CADL : 12.70 (-9.29%)
ABVC : 1.0600 (-1.85%)
CTMX : 2.0000 (+2.04%)
AMGN : 314.72 (-1.35%)
Biotech Innovations Surge as Global Cancer Diagnosis Rates Continue to Climb Newswire.ca - Thu May 9, 9:22AM CDT

/CNW/ -- In the fight against cancer, a political stumbling block was recently put in place by the US Congress after it voted against the renewal of funding...

ONCY : 1.1300 (-2.59%)
CADL : 12.70 (-9.29%)
AZN : 77.04 (+0.09%)
HALO : 45.39 (-0.94%)
JANX : 47.51 (+0.06%)
ONC.TO : 1.55 (-1.27%)
Rising Cancer Rates Drive Biotech Advancements Despite Political Hurdles BayStreet.ca - Thu May 9, 9:13AM CDT

USA News Group – In the fight against cancer, a political stumbling block was recently put in place by the US Congress after it voted against the renewal of funding for President Biden’s “Cancer...

ONCY : 1.1300 (-2.59%)
ONC.TO : 1.55 (-1.27%)
CADL : 12.70 (-9.29%)
AZN : 77.04 (+0.09%)
HALO : 45.39 (-0.94%)
JANX : 47.51 (+0.06%)
Biotech/Oncology Stocks Targeting the Pancreatic Cancer Market – A Race Worth FinancialNewsMedia - Wed Mar 6, 7:40AM CST

EQNX::TICKER_START (ONASDAQ:ONCY),(TSX:ONC),(NASDAQ:BLRX),(NASDAQ:IMRX),(NASDAQ:CADL) EQNX::TICKER_END

ONCY : 1.1300 (-2.59%)
ONC.TO : 1.55 (-1.27%)
BLRX : 0.6419 (+4.04%)
IMRX : 1.5400 (-1.91%)
CADL : 12.70 (-9.29%)
Candel Therapeutics Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights Globe Newswire - Fri Aug 5, 2022

NEEDHAM, Mass., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a late clinical stage...

CADL : 12.70 (-9.29%)
Candel Therapeutics Announces Release of Initial Data on CAN-2409 in a Phase 2 Clinical Trial Showing Cytotoxic T Cell Response and Disease Control in Patients with Non-Small Cell Lung Cancer Globe Newswire - Thu May 26, 2022

Disease control rate of 87.5 percent achieved in patients who were all progressing on anti-PD-1 therapy at trial entryDurable disease stabilization that...

CADL : 12.70 (-9.29%)
Candel Therapeutics Reports First Quarter 2022 Financial Results and Recent Corporate Highlights Globe Newswire - Thu May 12, 2022

Cash position bolstered through debt financing to support operations into the fourth quarter of 2023...

CADL : 12.70 (-9.29%)
Candel Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Highlights Globe Newswire - Tue Mar 29, 2022

-Cash position remains strong to support operations into the fourth quarter of 2023-...

CADL : 12.70 (-9.29%)
Candel Therapeutics Appoints Dr. Francesca Barone as Chief Scientific Officer Globe Newswire - Thu Feb 3, 2022

NEEDHAM, Mass., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Nasdaq: CADL), a late clinical stage biopharmaceutical company developing...

CADL : 12.70 (-9.29%)

Barchart Exclusives

Is It Too Late to Buy This Energy Dividend Stock at New Highs? Barchart - Thu May 16, 6:30PM CDT
Here's a closer look at whether Constellation Energy's recent surge to record highs presents a lucrative opportunity to buy into the bullish momentum, or whether investors should practice caution at the current valuation. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot